Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Terns Pharmaceuticals Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-05-31
Purchase
2022-06-08
9:28 pm
Terns Pharmaceuticals Inc. TERN Yoon Seokho Bryan
COO
7,656 $1.47 $11,254 7,656
(Direct)
View
2022-05-31
Purchase
2022-06-08
9:27 pm
Terns Pharmaceuticals Inc. TERN Vignola Mark J.
CFO
7,656 $1.47 $11,254 7,656
(Direct)
View
2022-05-31
Purchase
2022-06-08
9:27 pm
Terns Pharmaceuticals Inc. TERN Sundaram Senthil Vel
CEO
7,656 $1.47 $11,254 7,656
(Direct)
View
2021-02-09
Purchase
2021-02-09
3:10 pm
Terns Pharmaceuticals Inc. TERN GORDON CARL L
Director
10% Owner
475,000 $17 $8,075,000 2,274,723
(Indirect)
View
2021-02-09
Purchase
2021-02-09
3:09 pm
Terns Pharmaceuticals Inc. TERN ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
Director
10% Owner
475,000 $17 $8,075,000 2,274,723
(Indirect)
View
2021-02-09
Purchase
2021-02-09
3:08 pm
Terns Pharmaceuticals Inc. TERN Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
475,000 $17 $8,075,000 357,353
(Indirect)
View
2021-02-09
Purchase
2021-02-09
2:55 pm
Terns Pharmaceuticals Inc. TERN Flynn James E
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
DEERFIELD PARTNERS L.P.
Deerfield Mgmt L.P.
10% Owner
665,000 $17 $11,305,000 2,382,033
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-07-26
Option Award
2022-07-28
8:08 pm
N/A
2032-07-25
Terns Pharmaceuticals Inc. TERN Tripuraneni Radhika
Director
64,000 $0 64,000
(Direct)
View
2022-07-01
Option Award
2022-07-06
8:07 pm
N/A
2032-06-30
Terns Pharmaceuticals Inc. TERN Russell Kerry Strong
Chief Medical Officer
240,000 $0 240,000
(Direct)
View
2022-06-16
Option Award
2022-06-21
9:00 pm
N/A
2032-06-15
Terns Pharmaceuticals Inc. TERN Taylor Ann Elizabeth
Director
32,000 $0 32,000
(Direct)
View
2022-06-16
Option Award
2022-06-21
9:00 pm
N/A
2032-06-15
Terns Pharmaceuticals Inc. TERN Quigley Jill M.
Director
32,000 $0 32,000
(Direct)
View
2022-06-16
Option Award
2022-06-21
9:00 pm
N/A
2032-06-15
Terns Pharmaceuticals Inc. TERN FELLOWS DAVID A
Director
32,000 $0 32,000
(Direct)
View
2022-06-16
Option Award
2022-06-21
9:00 pm
N/A
2032-06-15
Terns Pharmaceuticals Inc. TERN GORDON CARL L
Director
10% Owner
32,000 $0 32,000
(Direct)
View
2022-06-16
Option Award
2022-06-21
9:00 pm
N/A
2032-06-15
Terns Pharmaceuticals Inc. TERN Lu Hongbo
Director
32,000 $0 32,000
(Direct)
View
2022-06-16
Option Award
2022-06-21
9:00 pm
N/A
2032-06-15
Terns Pharmaceuticals Inc. TERN KINDLER JEFFREY B
Director
32,000 $0 32,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
9:02 pm
N/A
2032-01-26
Terns Pharmaceuticals Inc. TERN Quirk Erin
President CMO and Head of R & D
92,500 $0 92,500
(Direct)
View
2022-01-26
Option Award
2022-01-28
9:02 pm
N/A
2032-01-26
Terns Pharmaceuticals Inc. TERN Vignola Mark J.
CFO
65,000 $0 65,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
9:01 pm
N/A
2032-01-26
Terns Pharmaceuticals Inc. TERN Yoon Seokho Bryan
COO
65,000 $0 65,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
9:00 pm
N/A
2032-01-26
Terns Pharmaceuticals Inc. TERN Sundaram Senthil Vel
CEO
280,000 $0 280,000
(Direct)
View
2021-09-28
Option Award
2021-10-12
9:20 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN Taylor Ann Elizabeth
Director
44,000 $0 44,000
(Direct)
View
2021-09-28
Option Award
2021-09-30
9:17 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN Yoon Seokho Bryan
COO
120,000 $0 120,000
(Direct)
View
2021-09-28
Option Award
2021-09-30
9:17 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN Vignola Mark J.
CFO
120,000 $0 120,000
(Direct)
View
2021-09-28
Option Award
2021-09-30
9:17 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN KINDLER JEFFREY B
Director
22,000 $0 22,000
(Direct)
View
2021-09-28
Option Award
2021-09-30
9:14 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN Quirk Erin
President and CMO
142,500 $0 142,500
(Direct)
View
2021-09-28
Option Award
2021-09-30
9:13 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN Sundaram Senthil Vel
CEO
315,000 $0 315,000
(Direct)
View
2021-09-28
Option Award
2021-09-30
9:11 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN Quigley Jill M.
Director
22,000 $0 22,000
(Direct)
View
2021-09-28
Option Award
2021-09-30
9:09 pm
N/A
2031-09-28
Terns Pharmaceuticals Inc. TERN FELLOWS DAVID A
Director
22,000 $0 22,000
(Direct)
View
2021-02-24
Option Award
2021-02-26
5:04 pm
N/A
2031-02-23
Terns Pharmaceuticals Inc. TERN Lu Hongbo
Director
25,000 $0 25,000
(Direct)
View
2021-02-24
Option Award
2021-02-26
5:03 pm
N/A
2031-02-23
Terns Pharmaceuticals Inc. TERN GORDON CARL L
Director
10% Owner
25,000 $0 25,000
(Direct)
View
2021-02-09
Conversion
2021-02-09
5:00 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN LAV Biosciences Fund V L.P.
Hopewell Resources Holdings Ltd
Oriental Spring Venture Ltd
LAV Aqua Ltd
10% Owner
6,068,264 $0 1,405,583
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:10 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN GORDON CARL L
Director
10% Owner
6,632,408 $0 2,274,723
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:09 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
Director
10% Owner
6,632,408 $0 2,274,723
(Indirect)
View
2021-02-09
Conversion
2021-02-09
3:08 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
3,426,240 $0 357,353
(Indirect)
View
2021-02-09
Conversion
2021-02-09
2:55 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN Flynn James E
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
DEERFIELD PARTNERS L.P.
Deerfield Mgmt L.P.
10% Owner
1,717,033 $0 2,382,033
(Indirect)
View
2020-02-04
Ownership
2021-02-04
7:55 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN Flynn James E
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
DEERFIELD PARTNERS L.P.
Deerfield Mgmt L.P.
10% Owner
0 $0 1,717,033
(Indirect)
View
2021-02-04
Ownership
2021-02-04
5:16 pm
N/A
2030-08-12
Terns Pharmaceuticals Inc. TERN Sundaram Senthil Vel
CEO
0 $0 949,197
(Direct)
View
2021-02-04
Ownership
2021-02-04
5:15 pm
N/A
2029-01-10
Terns Pharmaceuticals Inc. TERN Quirk Erin
See Remarks
0 $0 379,678
(Direct)
View
2021-02-04
Ownership
2021-02-04
5:14 pm
N/A
2030-09-09
Terns Pharmaceuticals Inc. TERN Vignola Mark J.
CFO
0 $0 227,807
(Direct)
View
2021-02-04
Ownership
2021-02-04
5:13 pm
N/A
2030-12-29
Terns Pharmaceuticals Inc. TERN Yoon Seokho Bryan
See Remarks
0 $0 265,775
(Direct)
View
2021-02-04
Ownership
2021-02-04
5:12 pm
N/A
N/A
Terns Pharmaceuticals Inc. TERN Zhong Weidong
Chief Scientific Officer
0 $0 513,520
(Direct)
View
2021-02-04
Ownership
2021-02-04
5:11 pm
N/A
2030-12-29
Terns Pharmaceuticals Inc. TERN Quigley Jill M.
Director
0 $0 28,475
(Direct)
View
Goto 0, 1, Next